Eric A. Meier, MD; Bonnie A. Whisman, MS; and Melinda M. Rathkopf, MD

Ann Allergy Asthma Immunol. 2006;96:30-32

Immunotherapy is effective in treating IgE-mediated condidtions, including Hymenoptera sesitivity, allergeic rhinitis, and allergic bronchial asthma. The criteria for starting immunotherapy include a hisory of significant allergen exposure, sensitivity to the allergen as demonstrated by the results of skin prick testing or in vitro testing for specific IgE, and a pattern of exposure to allegen that correlates with the pattern of symptoms. Atopic individuals are commonly sensitized to several allergens, and under these circumstances, immunotherapy containing all the relevant allergens is indicated.